REVVITY, INC Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
REVVITY, INC (RVTY) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$78.88 million for the 6-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-11
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-07-05 was -$4.19M.
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-04-05 was -$74.69M.
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-28 was $51.10M, a 44.95% decline year-over-year.
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-28 was -$19.81M.
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$17.89M.
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$21.40M.
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$291.81M.
- REVVITY, INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$236.62M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-07-05 | -$4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$78.88M 10-Q · filed 2026-08-11 | -$27.77M derived: sum of 3 quarters · filed 2026-08-11 | -$47.58M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-04-05 | -$74.69M 10-Q · filed 2026-05-12 | -$23.58M derived: sum of 2 quarters · filed 2026-05-12 | -$43.40M derived: sum of 3 quarters · filed 2026-05-12 | -$57.76M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-28 | $51.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $31.29M derived: sum of 2 quarters · filed 2026-02-24 | $16.93M derived: sum of 3 quarters · filed 2026-08-11 | -$17.89M 10-K · filed 2026-02-24 | ||
| 2025-09-28 | -$19.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$34.18M derived: sum of 2 quarters · filed 2026-08-11 | -$68.99M 10-Q · filed 2025-11-04 | $23.85M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-29 | -$14.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$49.18M 10-Q · filed 2026-08-11 | $43.66M derived: sum of 3 quarters · filed 2026-08-11 | -$17.68M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-30 | -$34.81M 10-Q · filed 2026-05-12 | $58.03M derived: sum of 2 quarters · filed 2026-05-12 | -$3.31M derived: sum of 3 quarters · filed 2026-05-12 | -$11.30M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-29 | $92.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $31.50M derived: sum of 2 quarters · filed 2026-02-24 | $23.51M derived: sum of 3 quarters · filed 2026-02-24 | -$21.40M 10-K · filed 2026-02-24 | ||
| 2024-09-29 | -$61.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$69.33M derived: sum of 2 quarters · filed 2025-11-04 | -$114.24M 10-Q · filed 2025-11-04 | -$83.06M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | -$7.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$52.89M 10-Q · filed 2025-08-05 | -$21.71M derived: sum of 3 quarters · filed 2026-02-24 | -$104.42M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | -$44.91M 10-Q · filed 2025-05-06 | -$13.73M derived: sum of 2 quarters · filed 2026-02-24 | -$96.44M derived: sum of 3 quarters · filed 2026-02-24 | -$230.13M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $31.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$51.53M derived: sum of 2 quarters · filed 2026-02-24 | -$185.22M derived: sum of 3 quarters · filed 2026-02-24 | -$291.81M 10-K · filed 2026-02-24 | ||
| 2023-10-01 | -$82.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$216.40M derived: sum of 2 quarters · filed 2024-11-06 | -$323.00M 10-Q · filed 2024-11-06 | -$199.53M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-07-02 | -$133.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$240.28M 10-Q · filed 2024-08-06 | -$116.82M derived: sum of 3 quarters · filed 2025-02-25 | -$206.70M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-04-02 | -$106.59M 10-Q · filed 2024-05-07 | $16.88M derived: sum of 2 quarters · filed 2025-02-25 | -$73.01M derived: sum of 3 quarters · filed 2025-02-25 | -$237.73M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-01-01 | $123.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $33.58M derived: sum of 2 quarters · filed 2025-02-25 | -$131.14M derived: sum of 3 quarters · filed 2025-02-25 | -$236.62M 10-K · filed 2025-02-25 | ||
| 2022-10-02 | -$89.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$254.61M derived: sum of 2 quarters · filed 2023-11-07 | -$360.09M 10-Q · filed 2023-11-07 | |||
| 2022-07-03 | -$164.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$270.21M 10-Q · filed 2023-08-09 | -$290.06M 10-Q · filed 2022-08-09 | |||
| 2022-04-03 | -$105.48M 10-Q · filed 2023-05-12 | -$122.52M 10-Q · filed 2022-05-10 | ||||
| 2021-10-03 | -$11.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$42.57M derived: sum of 2 quarters · filed 2022-11-14 | -$159.45M 10-Q · filed 2022-11-14 | |||
| 2021-07-04 | -$31.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$148.23M 10-Q · filed 2022-08-09 | ||||
| 2021-04-04 | -$116.88M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |